Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

James Martin

Plastic Surgery within the Head & Neck Highlands, NC Medical Doctor

NPI 1477536985 CMS profile 339436

209 Hospital Dr Ste 104, Highlands, NC 28741

Open in the dashboard

General payments

$2,467

40 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, James Martin of Highlands, NC is reported in the CMS Open Payments database as having received $2,467 across 40 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $144 1
2021 General $1,150 19
2020 General $298 5
2019 General $874 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Martin
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to James Martin were reported at $0. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year James Martin Plastic Surgery within the Head & Neck median Middle half National median
2019 $874 $200 $82–$550 $163
2020 $298 $120 $46–$330 $114
2021 $1,150 $166 $60–$382 $132
2022 $144 $208 $83–$530 $149
2023 $0 $202 $77–$538 $160
2024 $0 $260 $99–$645 $164
2025 $0 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Intersect ENT, Inc. $1,310 10 payments
  2. OptiNose US, Inc. $309 13 payments
  3. Regeneron Healthcare Solutions, Inc. $181 4 payments
  4. Aerin Medical Inc. $164 2 payments
  5. ALK-Abello, Inc $142 3 payments
  6. Arrinex, Inc. $131 1 payment
  7. Acclarent, Inc $129 1 payment
  8. Genzyme Corporation $49 2 payments
  9. Novartis Pharmaceuticals Corporation $28 2 payments
  10. Glenmark Therapeutics Inc. $12 1 payment
  11. Other $9 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,467 40 payments
Products named General payments · program years 2019–2022
  1. PROPEL Otolaryngology (Ear, Nose, Throat) $882 7 payments
  2. Xhance $309 13 payments
  3. SINUVA $284 2 payments
  4. DUPIXENT Inflammation And Immunology $181 4 payments
  5. PROPEL Otolaryngology (Ear, Nose, Throat) $144 1 payment
  6. Otiprio $142 3 payments
  7. CLARIFIX $141 2 payments
  8. ACCLARENT ENT ULTIRRA/NAVWIRE 3-GUIDE Bundle $129 1 payment
  9. Vivaer RF Stylus $114 1 payment
  10. DUPIXENT Immunology $50 2 payments
  11. Other $164 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

40 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery within the Head & Neck in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record